Editas: Q3 Earnings Snapshot
In this article:
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Editas Medicine Inc. (EDIT) on Friday reported a loss of $45 million in its third quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 55 cents.
The results exceeded Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 64 cents per share.
The genome editing company posted revenue of $5.3 million in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $5.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT
